Y‐F Liaw

1.0k total citations
20 papers, 840 citations indexed

About

Y‐F Liaw is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Y‐F Liaw has authored 20 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Y‐F Liaw's work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Y‐F Liaw is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Y‐F Liaw collaborates with scholars based in Taiwan, United States and Australia. Y‐F Liaw's co-authors include Chin‐Chang Huang, George Kuo, Su‐Jen Lin Tsai, Margaret Chen, Chung‐Ming Chu, Ming‐Whei Yu, C-J Chen, Paul Lin, Lan‐Yan Yang and Pei‐Jer Chen and has published in prestigious journals such as Gastroenterology, Hepatology and Oncogene.

In The Last Decade

Y‐F Liaw

20 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y‐F Liaw Taiwan	12	648	583	120	84	65	20	840
P H McGuinness Australia	6	537 0.8×	413 0.7×	165 1.4×	117 1.4×	64 1.0×	9	688
J Eisenburg Germany	16	383 0.6×	454 0.8×	249 2.1×	41 0.5×	61 0.9×	37	737
John Napoli Australia	10	471 0.7×	376 0.6×	180 1.5×	120 1.4×	87 1.3×	14	795
Elisabetta Degasperi Italy	19	887 1.4×	918 1.6×	79 0.7×	66 0.8×	102 1.6×	82	1.2k
H. Kumada Japan	14	999 1.5×	879 1.5×	38 0.3×	137 1.6×	68 1.0×	29	1.1k
Efsevia Albanis United States	11	919 1.4×	882 1.5×	73 0.6×	38 0.5×	96 1.5×	11	1.1k
Su‐Jen Lin Tsai Taiwan	7	383 0.6×	298 0.5×	119 1.0×	77 0.9×	34 0.5×	8	539
Bradley Freilich United States	9	576 0.9×	655 1.1×	80 0.7×	27 0.3×	88 1.4×	14	828
Wiesław Kryczka Poland	12	479 0.7×	483 0.8×	35 0.3×	35 0.4×	106 1.6×	34	651
Daniel J. Felmlee United Kingdom	17	818 1.3×	735 1.3×	78 0.7×	178 2.1×	129 2.0×	34	1.0k

Countries citing papers authored by Y‐F Liaw

Since Specialization

Citations

This map shows the geographic impact of Y‐F Liaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y‐F Liaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y‐F Liaw more than expected).

Fields of papers citing papers by Y‐F Liaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y‐F Liaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y‐F Liaw. The network helps show where Y‐F Liaw may publish in the future.

Co-authorship network of co-authors of Y‐F Liaw

This figure shows the co-authorship network connecting the top 25 collaborators of Y‐F Liaw. A scholar is included among the top collaborators of Y‐F Liaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y‐F Liaw. Y‐F Liaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gartner, Matthew J., Monique L. Smith, Clyde Dapat, et al.. (2025). Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains. Journal of Virology. 99(9). e0068425–e0068425. 1 indexed citations

Chu, Chung‐Ming, et al.. (2012). Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection. British Journal of Cancer. 107(12). 2010–2015. 27 indexed citations

Yu, Ming‐Whei, Chun‐Jen Liu, Wei‐Liang Shih, et al.. (2007). Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut. 57(1). 91–97. 89 indexed citations

Chu, Chung‐Ming, et al.. (2006). Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?. International Journal of Obesity. 31(5). 871–875. 85 indexed citations

Sherman, Morris, L. Jeffers, Albert D. Min, et al.. (2006). Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-week. 1 indexed citations

Lai, Ching‐Lung, E. Gane, Y‐F Liaw, et al.. (2005). Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial. 30 indexed citations

Shih, Wei‐Liang, Ming‐Whei Yu, Pei‐Jer Chen, et al.. (2005). Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area. Oncogene. 25(22). 3219–3224. 13 indexed citations

Lai, Ching‐Lung, Edward Gane, Y‐F Liaw, et al.. (2005). Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study). 11 indexed citations

Liaw, Y‐F, et al.. (2003). UNINTENTIONAL RECHALLENGE RESULTING IN A CAUSATIVE RELATIONSHIP BETWEEN KETOCONAZOLE AND ACUTE LIVER INJURY. International Journal of Clinical Practice. 57(9). 829–830. 7 indexed citations

10.

Liaw, Y‐F, et al.. (2003). 220 Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blind placebo-controlled clinical trial. Hepatology. 38. 262–263. 18 indexed citations

11.

Farrell, GC, Y‐F Liaw, & Geoffrey W. McCaughan. (2000). JGH and Asia–Pacific consensus on prevention and management of gastrointestinal and liver diseases. Journal of Gastroenterology and Hepatology. 15(8). 815–818. 27 indexed citations

12.

Yu, Ming‐Whei, et al.. (1999). Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. British Journal of Cancer. 80(3-4). 598–603. 57 indexed citations

13.

Liaw, Y‐F, et al.. (1998). Two-year lamivudine therapy in chronic hepatitis B infection: Results of a placebo controlled multicentre study in Asia. Gastroenterology. 114. A1289–A1289. 34 indexed citations

14.

Yang, Lan‐Yan, et al.. (1997). Hepatic Injury During Ketoconazole Therapy in Patients With Onychomycosis: A Controlled Cohort Study. Hepatology. 25(1). 103–107. 56 indexed citations

15.

Tsai, Su‐Jen Lin, Y‐F Liaw, Margaret Chen, Chin‐Chang Huang, & George Kuo. (1997). Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus Chronicity. Hepatology. 25(2). 449–458. 350 indexed citations

16.

Liaw, Y‐F. (1995). Acute exacerbation and superinfection in patients with chronic viral hepatitis.. PubMed. 94(9). 521–8. 21 indexed citations

17.

Liaw, Y‐F, et al.. (1995). [Drug therapy in patients with chronic type B hepatitis].. PubMed. 94 Suppl 1. S1–9. 5 indexed citations

18.

Liaw, Y‐F, et al.. (1993). Increased sister chromatid exchange frequency in peripheral lymphocytes of hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology. 8(S1). 1 indexed citations

19.

Liaw, Y‐F, et al.. (1990). Randomized controlled trial of recombinant interferon alfa-2b in chronic NANB hepatitis: Dose schedules and results. Journal of Hepatology. 11. S160–S160. 2 indexed citations

20.

Jl, Sung, et al.. (1979). A survey and follow-up study of anicteric hepatitis, other asymptomatic liver diseases and hepatitis B surface antigen carriers.. PubMed. 78(5). 452–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact